Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial of Eribulin in Advanced or Recurrent Cervical Cancer

NCT01676818 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01676818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01676818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial of Eribulin in Advanced or Recurrent Cervical Cancer
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Completed
Start date
August 9, 2012
Completion date
December 22, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent cervical cancer, stage iiia cervical cancer, stage iiib cervical cancer, stage iva cervical cancer, stage ivb cervical cancer